Healthcare Unfiltered Express
Dr. Matt Davids of the Dana Farber Cancer Institute joins Healthcare Unfiltered EXPRESS to share his data-solidified insights on navigating the treatment of relapsed/refractory (R/R) CLL, considering the welcome advances the field has witnessed in treating front-line disease. Check it out, subscribe, rate, and join the conversation.
56 episoder
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af Healthcare Unfiltered Express-fællesskabet!